chr8-27777059-G-GA

Variant summary

Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong

The NM_001017420.3(ESCO2):​c.760dupA​(p.Thr254AsnfsTer27) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000827 in 1,596,346 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000089 ( 0 hom. )

Consequence

ESCO2
NM_001017420.3 frameshift

Scores

Not classified

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:4O:1

Conservation

PhyloP100: 0.892

Publications

8 publications found
Variant links:
Genes affected
ESCO2 (HGNC:27230): (establishment of sister chromatid cohesion N-acetyltransferase 2) This gene encodes a protein that may have acetyltransferase activity and may be required for the establishment of sister chromatid cohesion during the S phase of mitosis. Mutations in this gene have been associated with Roberts syndrome. [provided by RefSeq, Jul 2008]
ESCO2 Gene-Disease associations (from GenCC):
  • Roberts-SC phocomelia syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, G2P, Labcorp Genetics (formerly Invitae)
  • Roberts syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 16 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant 8-27777059-G-GA is Pathogenic according to our data. Variant chr8-27777059-G-GA is described in ClinVar as Pathogenic. ClinVar VariationId is 1738.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ESCO2NM_001017420.3 linkc.760dupA p.Thr254AsnfsTer27 frameshift_variant Exon 3 of 11 ENST00000305188.13 NP_001017420.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ESCO2ENST00000305188.13 linkc.760dupA p.Thr254AsnfsTer27 frameshift_variant Exon 3 of 11 1 NM_001017420.3 ENSP00000306999.8

Frequencies

GnomAD3 genomes
AF:
0.0000198
AC:
3
AN:
151244
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000486
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000376
AC:
85
AN:
225828
AF XY:
0.000392
show subpopulations
Gnomad AFR exome
AF:
0.0000663
Gnomad AMR exome
AF:
0.000867
Gnomad ASJ exome
AF:
0.000801
Gnomad EAS exome
AF:
0.000243
Gnomad FIN exome
AF:
0.000193
Gnomad NFE exome
AF:
0.000267
Gnomad OTH exome
AF:
0.000374
GnomAD4 exome
AF:
0.0000893
AC:
129
AN:
1445102
Hom.:
0
Cov.:
32
AF XY:
0.0000863
AC XY:
62
AN XY:
718328
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000185
AC:
6
AN:
32454
American (AMR)
AF:
0.000789
AC:
33
AN:
41846
Ashkenazi Jewish (ASJ)
AF:
0.000195
AC:
5
AN:
25660
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39448
South Asian (SAS)
AF:
0.000121
AC:
10
AN:
82886
European-Finnish (FIN)
AF:
0.0000754
AC:
4
AN:
53028
Middle Eastern (MID)
AF:
0.000175
AC:
1
AN:
5706
European-Non Finnish (NFE)
AF:
0.0000579
AC:
64
AN:
1104452
Other (OTH)
AF:
0.000101
AC:
6
AN:
59622
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.296
Heterozygous variant carriers
0
16
32
47
63
79
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000198
AC:
3
AN:
151244
Hom.:
0
Cov.:
33
AF XY:
0.00
AC XY:
0
AN XY:
73808
show subpopulations
African (AFR)
AF:
0.0000486
AC:
2
AN:
41182
American (AMR)
AF:
0.00
AC:
0
AN:
15156
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3462
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4794
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10378
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
67798
Other (OTH)
AF:
0.00
AC:
0
AN:
2072
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000663
Hom.:
0

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:4Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Roberts-SC phocomelia syndrome Pathogenic:1Other:1
-
GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only

- -

Dec 01, 2005
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

ESCO2-related disorder Pathogenic:1
Apr 11, 2024
PreventionGenetics, part of Exact Sciences
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

The ESCO2 c.760dupA variant is predicted to result in a frameshift and premature protein termination (p.Thr254Asnfs*27). This variant was reported to be pathogenic for Roberts Syndrome/SC Phocomelia (see examples: reported as c.751-752insA in Family A, Schule et al. 2005. PubMed ID: 16380922; reported as c.760_761insA, McKay et al. 2018. PubMed ID: 30508616). This variant is reported in 0.084% of alleles in individuals of Latino descent in gnomAD. Frameshift variants in ESCO2 are expected to be pathogenic. This variant is interpreted as pathogenic. -

not provided Pathogenic:1
Dec 05, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change creates a premature translational stop signal (p.Thr254Asnfs*27) in the ESCO2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ESCO2 are known to be pathogenic (PMID: 15821733, 16380922). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with Roberts syndrome (PMID: 18411254, 30508616). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 1738). For these reasons, this variant has been classified as Pathogenic. -

Roberts-SC phocomelia syndrome;C0796099:Juberg-Hayward syndrome Pathogenic:1
May 23, 2024
Fulgent Genetics, Fulgent Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.89
Mutation Taster
=3/197
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.050
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs80359852; hg19: chr8-27634576; COSMIC: COSV59413298; COSMIC: COSV59413298; API